Related Experiment Video

Updated: Jul 19, 2025

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

9.0K

Blocking Netrin-1 Slows Cancer Progression

    Cancer Discovery
    |August 18, 2023
    PubMed

    Insights

    The netrin-1 inhibitor NP137 shows promise in halting endometrial cancer progression by blocking epithelial-to-mesenchymal transition. Further studies are required to explore its mechanism and potential in other cancer types.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Cancer Therapeutics

    Background:

    • Endometrial cancer is a significant gynecologic malignancy.
    • The epithelial-to-mesenchymal transition (EMT) is a critical process in cancer progression and metastasis.
    • Netrin-1 signaling plays a role in various cancers, including endometrial cancer.

    Purpose of the Study:

    • To evaluate the efficacy of the netrin-1 inhibitor NP137 in preclinical and early clinical settings for endometrial cancer.
    • To investigate the impact of NP137 on epithelial-to-mesenchymal transition and disease progression.
    • To explore the potential of NP137 in combination with chemotherapy and its applicability to other cancer types.

    Main Methods:

    • Preclinical studies involving relevant cancer models.
    • Early-phase clinical trials assessing NP137 treatment.
    • Analysis of biomarkers related to EMT and disease progression.

    Main Results:

    • Preclinical and early clinical data indicate that NP137 can inhibit EMT.
    • Treatment with NP137 demonstrated a positive effect on arresting disease progression in endometrial cancer models.
    • The study provides preliminary evidence for the therapeutic potential of NP137.

    Conclusions:

    • NP137 shows potential as a targeted therapy for endometrial cancer by inhibiting EMT.
    • Further research is warranted to elucidate the precise mechanism of action of NP137, particularly in combination with chemotherapy.
    • Investigating the broader applicability of NP137 in other malignancies is a crucial next step.

    More Related Videos

    Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

    Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

    Published on: July 20, 2019

    6.0K
    CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

    CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

    Published on: June 2, 2022

    2.7K

    Related Concept Videos

    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
    4.1K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    3.8K
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    6.4K
    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    5.8K
    Cancer Cell Migration through Invadopodia01:35

    Cancer Cell Migration through Invadopodia

    Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
    2.3K
    Non-Canonical Wnt Signaling Pathways01:41

    Non-Canonical Wnt Signaling Pathways

    Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
    7.3K